Molecular pathways: the role of NR4A orphan nuclear receptors in cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Helen M MohanEvelyn P Murphy

Abstract

Nuclear receptors are of integral importance in carcinogenesis. Manipulation of classic ligand-activated nuclear receptors, such as estrogen receptor blockade in breast cancer, is an important established cancer therapy. Orphan nuclear receptors, such as nuclear family 4 subgroup A (NR4A) receptors, have no known natural ligand(s). These elusive receptors are increasingly recognized as molecular switches in cell survival and a molecular link between inflammation and cancer. NR4A receptors act as transcription factors, altering expression of downstream genes in apoptosis (Fas-ligand, TRAIL), proliferation, DNA repair, metabolism, cell migration, inflammation (interleukin-8), and angiogenesis (VEGF). NR4A receptors are modulated by multiple cell-signaling pathways, including protein kinase A/CREB, NF-κB, phosphoinositide 3-kinase/AKT, c-jun-NH(2)-kinase, Wnt, and mitogen-activated protein kinase pathways. NR4A receptor effects are context and tissue specific, influenced by their levels of expression, posttranslational modification, and interaction with other transcription factors (RXR, PPAR-Υ). The subcellular location of NR4A "nuclear receptors" is also important functionally; novel roles have been described in the cytoplasm whe...Continue Reading

References

May 26, 1999·American Journal of Respiratory Cell and Molecular Biology·Y UedaJ Takahara
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·Xiao feng YeWen jin Su
Nov 13, 2003·Molecular and Cellular Biology·Siva Kumar KolluriXiao-kun Zhang
Dec 16, 2003·Biochemical and Biophysical Research Communications·Mariette NordzellThomas Perlmann
May 6, 2005·The Journal of Biological Chemistry·Sudhakar ChintharlapalliStephen Safe
Jun 14, 2005·Atherosclerosis·Jordi RiusLina Badimon
Nov 19, 2005·The Journal of Biological Chemistry·Vijaykumar R HollaRaymond N DuBois
Mar 8, 2006·The Journal of Experimental Medicine·Huiyan ZengHarold F Dvorak
Aug 22, 2007·Molecular and Cellular Biology·Hirochika KitagawaLeonard P Freedman
Aug 12, 2008·Nature Chemical Biology·Yanyan ZhanQiao Wu
Aug 30, 2008·Clinical Endocrinology·Cléber P CamachoJanete M Cerutti
Oct 7, 2008·Cancer Cell·Siva Kumar KolluriXiao-kun Zhang
Aug 13, 2009·Molecular Cancer Research : MCR·Tao ZhangGuanghui Wang
Apr 16, 2010·Molecular Endocrinology·Michael A Pearen, George E O Muscat
Jun 26, 2010·Endocrine-related Cancer·Rebecca B RigginsRobert Clarke
Aug 18, 2010·International Journal of Cancer. Journal International Du Cancer·Dezheng ZhaoHuiyan Zeng
Sep 18, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hua WuJin-Zhang Zeng
Feb 15, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hui YangYu-Jui Yvonne Wan
Mar 3, 2011·Archives of Biochemistry and Biophysics·Ann-Marie Rajalin, Piia Aarnisalo
Mar 25, 2011·Biochemical Society Transactions·Jason P McMorrow, Evelyn P Murphy
Apr 7, 2011·Nature Communications·Takashi SekiyaAkihiko Yoshimura
Jul 16, 2011·The Journal of Biological Chemistry·Vijaykumar R HollaRaymond N DuBois

❮ Previous
Next ❯

Citations

Oct 1, 2013·Diabetes & Metabolism·A F CloseJ Buteau
Apr 29, 2015·The Journal of Steroid Biochemistry and Molecular Biology·Stephen SafeRonald B Tjalkens
Dec 24, 2014·Journal of Molecular and Cellular Cardiology·Olivier CalvayracJosé Martínez-González
Jun 28, 2015·Prostaglandins & Other Lipid Mediators·Hongya HanHans-Erik Claesson
Mar 27, 2015·Thrombosis and Haemostasis·Ricardo Rodríguez-CalvoJosé Martínez-González
Nov 2, 2013·Genesis : the Journal of Genetics and Development·Chris R GissendannerBrian G Rowan
Dec 23, 2014·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Brandon Praslicka, Chris R Gissendanner
Oct 7, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lei ZhouHuiyan Zeng
Nov 26, 2015·The Journal of Experimental Medicine·Binh L PhongLawrence P Kane
Dec 21, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Apurva R PatelMandip Singh
Aug 5, 2014·Journal of Receptor and Signal Transduction Research·Harmit S Ranhotra
Mar 27, 2013·Journal of Receptor and Signal Transduction Research·Harmit S Ranhotra
Dec 30, 2014·Medical Hypotheses·Michael R Paillasse, Philippe de Medina
May 31, 2014·Neurobiology of Disease·Rebecca SkerrettGary Landreth
Dec 3, 2014·Cancer Treatment Reviews·Mani Roshan-MoniriPaul S Rennie
Apr 12, 2014·Brain : a Journal of Neurology·Tsz Hang WongJohn van Swieten
Jan 4, 2015·Steroids·Alicja PawlakWojciech Kalas
Nov 20, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Briana R De MirandaRonald B Tjalkens
May 11, 2016·Neurotoxicity Research·Francesca MontaroloAntonio Bertolotto
May 18, 2016·Scientific Reports·Beatriz FerránJosé Martínez-González
Jun 7, 2016·Biochimica Et Biophysica Acta·Dinglan WuFranky L Chan
Aug 22, 2016·Cellular and Molecular Life Sciences : CMLS·Kelvin Yin, Aaron G Smith
Feb 4, 2016·PloS One·Alexa TengaTaosheng Chen
Jul 2, 2014·Biochimica Et Biophysica Acta·Marta Kostrouchova, Zdenek Kostrouch
Jan 25, 2018·Journal of Cellular Biochemistry·Mansi ShuklaSubeer S Majumdar
Dec 13, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Judith F Ashouri, Arthur Weiss
Oct 8, 2013·Journal of Molecular Endocrinology·Shannon E MullicanMitchell A Lazar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

© 2021 Meta ULC. All rights reserved